Share
Journal Information
Most often read
2009
Diagnostic stability in substance-induced psychosisLucía Inchausti, Iñigo Gorostiza, Miguel Angel Gonzalez Torres, Rodrigo Oraa
Rev Psiquiatr Salud Ment. 2022;15:272-80
2009
Full text access
Open Article
1926
Different measures for auditory hallucinations in populations with psychosis. The Validation of the Spanish versions of the Auditory Vocal Hallucination Rating Scale (AVHRS) and the Positive and Useful Voices Inquiry (PUVI)Esther Lorente-Rovira, Eva Grasa, Susana Ochoa, Iluminada Corripio, Trinidad Peláez, Raquel López-Carrilero, Ángela Gutiérrez-Gea, María Morano-Guillén, ... Julio Sanjuán
Rev Psiquiatr Salud Ment. 2022;15:259-71
1926
Full text access
Open Article
1052
Clinical symptoms and social functioning in schizophreniaMaria Jose Escandell, Gemma Prat, Mar Garcia-Franco, Jose Ramón Martín-Martínez, Susana Ochoa, Ingrid Tortades, Sonia Vilamala, Marina Verdaguer-Rodríguez, Emma Casas-Anguera
Rev Psiquiatr Salud Ment. 2022;15:251-8
1052
Full text access
Open Article
836
Risk factors of deficit and non-deficit schizophrenia: Results from a cross-sectional studyAgnieszka Cyran, Patryk Piotrowski, Jerzy Samochowiec, Tomasz Grąźlewski, Błażej Misiak
Rev Psiquiatr Salud Ment. 2022;15:223-9
836
Full text access
Open Article
826
Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countriesCarlos De las Cuevas, Emilio J. Sanz, Can-Jun Ruan, Jose de Leon
Rev Psiquiatr Salud Ment. 2022;15:238-50
826
Full text access
Open Article
680
A Covid-19 outbreak in a Spanish long-term psychiatric hospital led to infections in 6 clozapine patients: elevations in their plasma clozapine levelsManuel Arrojo-Romero, Maria Rosario Codesido-Barcala, Jose de Leon
Rev Psiquiatr Salud Ment. 2022;15:290-2
680
Full text access
Open Article
603
A clozapine's uncharted voyage: Five years and a pandemic after the end of mandatory haematological notifications to the Spanish medicines agencyPilar Andres-Olivera, Concha Turrion, Emilio Fernandez-Egea, Jesus Perez
Rev Psiquiatr Salud Ment. 2022;15:293-4
603
Full text access
Open Article
598
Here we go again! Subtyping diagnosis and refining treatmentsJavier Vázquez-Bourgon
Rev Psiquiatr Salud Ment. 2022;15:221-2
598
Full text access
Open Article
591
Dried Blood Spot (DBS) as a useful tool to improve clozapine, aripiprazole and paliperidone treatment: From adherence to efficiencyMiguel Bernardo, Gisela Mezquida, Paula Ferré, Bibiana Cabrera, Mercè Torra, Ana Maria Lizana, Mercè Brunet
Rev Psiquiatr Salud Ment. 2022;15:230-7
591
Full text access
Open Article
552
Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: A re-analysis of a Turkish case seriesAygün Ertuğrul, A. Elif Anıl Yağcıoğlu, Esen Ağaoğlu, Ahmet Alp Karakaşlı, Sertaç Ak, M. Kâzım Yazıcı, Jose de Leon
Rev Psiquiatr Salud Ment. 2022;15:281-6
552
Full text access
Open Article
525
Clozapine for the treatment of pediatric encephalopathy associated with nonketotic hyperglycinemiaSara Jiménez-Fernández, Manuel Gurpegui, Jose de Leon, Luis Gutiérrez-Rojas
Rev Psiquiatr Salud Ment. 2022;15:287-9
525
Full text access
Open Article
445
Clozapine-induced myocarditis in Russia: Animal studies but no clinical studiesOleg O. Kirilochev, Carlos De las Cuevas, Jose de Leon
Rev Psiquiatr Salud Ment. 2022;15:294-5
445
Full text access
Open Article